SQZ BIOTECHNOLOGIES CO's ticker is SQZ and the CUSIP is 78472W104. A total of 53 filers reported holding SQZ BIOTECHNOLOGIES CO in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $8,376 | -51.8% | 31,022 | 0.0% | 0.00% | – |
| Q1 2023 | $17,372 | -24.3% | 31,022 | 0.0% | 0.00% | – |
| Q4 2022 | $22,956 | -67.7% | 31,022 | 0.0% | 0.00% | – |
| Q3 2022 | $71,000 | -28.3% | 31,022 | 0.0% | 0.00% | – |
| Q2 2022 | $99,000 | -88.7% | 31,022 | -82.9% | 0.00% | – |
| Q1 2022 | $873,000 | -49.8% | 181,537 | -6.7% | 0.00% | – |
| Q4 2021 | $1,739,000 | -38.0% | 194,668 | +0.0% | 0.00% | – |
| Q3 2021 | $2,807,000 | +5.8% | 194,636 | +6.0% | 0.00% | – |
| Q2 2021 | $2,654,000 | +203.3% | 183,674 | +186.9% | 0.00% | – |
| Q1 2021 | $875,000 | -44.8% | 64,012 | +17.0% | 0.00% | – |
| Q4 2020 | $1,586,000 | – | 54,708 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NanoDimension, Inc. | 1,445,221 | $12,906,000 | 11.57% |
| 683 Capital Management, LLC | 1,852,135 | $16,540,000 | 0.61% |
| Sandy Cove Advisors, LLC | 51,707 | $462,000 | 0.39% |
| Artal Group S.A. | 1,606,309 | $14,344,000 | 0.39% |
| AMERICAN INTERNATIONAL GROUP, INC. | 2,529,272 | $22,586,000 | 0.11% |
| MAVERICK CAPITAL LTD | 1,056,786 | $9,437,000 | 0.11% |
| ACT CAPITAL MANAGEMENT, LLC | 16,000 | $143,000 | 0.10% |
| Temasek Holdings (Private) Ltd | 2,758,169 | $24,630,000 | 0.09% |
| BBR PARTNERS, LLC | 73,599 | $657,000 | 0.08% |
| Redmond Asset Management, LLC | 17,206 | $154,000 | 0.04% |